[Hepatitis C in Scandinavia].
The Nordic countries constitute a low hepatitis C prevalence area, only 0.05-0.30 percent of new blood donors are being found to be seropositive. However, hepatitis C is very common among such risk groups as intravenous drug abusers and patients with bleeding disorders. Though normally mild in the acute phase, hepatitis C usually results in a permanent carrier state and often in chronic asymptomatic liver inflammation, even liver cirrhosis in some cases. Therapeutic guidelines are still in the process of development, and intensive studies of alpha-interferon and oral tribavirin are in progress also in the Nordic countries.
Ebeling
F
F
Finlands Röda Kors Blodtjänst, Helsingfors.
D002353:Carrier State; D006467:Hemophilia A / Q000150:complications; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use; D012307:Risk Factors; D012537:Scandinavian and Nordic Countries / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000150:complications
D016898:Interferon-alpha; D012254:Ribavirin
Hepatit C i Norden.